The goal of this session is to present the busy practitioner with a concise review of GAD, panic disorder, and SAD. The presentation will breifly discuss changes in our nosology as we move from DSM 5 to DSM 5TR and any implications this may have for diagnosis of these syndromes. Next, we will discuss an approach to conceptualizing how the social determinants of health and mental health may impact the pathogensis, recognition and treatment of anxiety disorders. The next portion of the presentation will focus on treatment options for patients with anxiety disorders. We will briefly discuss evidence-based psychotherapies and complementary and alternative treatment options but we will focus mainly on exisiting pharmacological treatment approaches for patients with anxiety disorders. We will discuss the value of both FDA-approved and non-FDA approved pharmacological strategies that can be employed depending on the severity and degress of treatment non-response encountered. The final component of this lecutre will explore how new technologies may play a disruptive influence on how we recognize people at risk for developing these syndromes, lead to preventative if not pre-emptive interventions, and may extend our treatment options.
Format
Recorded webinar, non-interactive, self-paced distance learning activity.
This presentation was recorded at the American Psychiatric Association Annual Meeting 2022.
Learning Objectives
- Develop personalized treatment strategies for GAD, Panic Disorder, and SAD
- Discuss with patients the pros and cons of current integrative therapies for anxiety
- Discern how big data and AI may impact practice patterns in the future
- Identify future potentially disruptive treatment approaches
Target Audience
Psychiatrists
Estimated Time to Complete
Estimated Duration: 90 minutes
Begin Date: July 1, 2023
End Date: July 1, 2026
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the event date and hours earned.
Continuing Education Credit
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The APA designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Program Presenters
- Mark Rapaport, MD, University of Utah. Reports no financial relationships with commercial interests.
- Edmond Pi, MD, University of Southern California. Reports no financial relationships with commercial interests.
Program Planners
- Jacqueline Maus Feldman, M.D., Chairperson, Scientific Program Committee, Reports no financial relationships with commercial interests.
- Robert O. Cotes, M.D., Vice-Chairperson, Scientific Program Committee, Reports no financial relationships with commercial interests.
- Uchenna Okeye, M.D., Vice-Chairperson, Scientific Program Committee, Reports no financial relationships with commercial interests.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance